RAG-17, a Novel siRNA Therapy for SOD1-ALS: Safety and Preliminary Efficacy from a First-in-human Trial (S5.003)

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Neurology

Topics

Medicine

Internal Medicine

Neurology

Clinical Trial

Sod1

Show all topics

DOI

10.1212/wnl.0000000000212372